Dr. Lutz on sexual dysfunction, performance anxiety, and Peyronie's disease

The TAVT-45 formulation of abiraterone acetate was created for patients with dysphagia, who would have difficulty swallowing a tablet.

"I think there's a lot of fear that can go into talking about these topics," says Katherine Rotker, MD.

The TAVT-45 formulation of abiraterone consists of granules for oral suspension and was created for patients with dysphagia who would have difficulty swallowing a tablet.

"Hopefully, this will be a resource for people who are preparing for birth, or who have recently experienced birth," says Linda Brubaker, MD, MS.

In this interview, Kenneth M. Kernen, MD, describes his practice’s Jelmyto program and offers advice for urologists interested in implementing it in their practice.

MIU seizes innovation opportunities presented by dynamic national urology platform caring for nearly one-half million patients.